Trial · NCT03866395
Effects of Ivabradine on Residual Myocardial Ischemia After PCI
NCT03866395, Phase 4, Completed, Azienda Policlinico Umberto I
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Ivabradine on Residual Myocardial Ischemia After PCI. Trials, record NCT03866395. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03866395
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Ivabradine on Residual Myocardial Ischemia After PCI
- NCT number
- NCT03866395
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 28 participants, actual
- Lead sponsor
- Azienda Policlinico Umberto I
- Conditions
- Angina Pectoris, Stable
- Interventions
- Ivabradine
- First posted
- 2019-03-07
- Last updated
- 2019-03-07
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Double product (DP) calculated as a product between HR and systolic blood pressure. (unit of measure: beats per minute x mmHg) | 30 days | These, indirectly, reflect the true myocardial oxygen consumption (MVO2) and the improvement of mechanical load that the ventricle can withstand at different levels of exercise. |
| Primary | Triple product (TP), calculated as a product between HR, systolic blood pressure and ejection time. (unit of measure: beats per minute x mmHg x msec) | 30 days | These, indirectly, reflect the true myocardial oxygen consumption (MVO2) and the improvement of mechanical load that the ventricle can withstand at different levels of exercise. |
| Primary | chronotropic reserve (unit of measure: beats per minute) | 30 days | difference between resting heart rate and maximum heart rate at peak exercise |
| Primary | muscular work (unit of measure: watt) | 30 days | These, indirectly, reflect the myocardial oxygen consumption (MVO2) and the improvement of mechanical load that the ventricle can withstand at different levels of exercise. |
| Secondary | diastolic function: PW Doppler E wave (unit of measure: cm/sec) | 30 days | ventricular filling echocardiographic parameter |
| Secondary | diastolic function: TDI derived E' measurements (unit of measure: cm/sec) | 30 days | ventricular filling echocardiographic parameter. Mitral annular E' velocity was estimated as the average between lateral and septal velocity. |
| Secondary | diastolic function: PW Doppler A wave (unit of measure: cm/sec) | 30 days | ventricular filling echocardiographic parameter |
| Secondary | E/E' ratio | 30 days | ventricular filling echocardiographic parameter. TDI derived E' measurements (unit of measure: cm/sec). PW Doppler E wave (unit of measure: cm/sec) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03866395
GET https://conductscience.org/api/trials/v1/NCT03866395/registered